In the Press

COVID-19 mRNA booster vaccines offered protection against severe COVID-19 caused by the Omicron variant for at least 6 months, and three doses of China's inactivated vaccines were more protective than two doses but not as protective as three doses of mRNA vaccines, finds a study from Singapore published today in JAMA Network Open.

COVID-19 and monkeypox are pretty different diseases. But the parallels between the nation’s yearslong, languishing response to the coronavirus pandemic and the emerging monkeypox outbreak are many – and potentially agonizing.

Moderna yesterday announced that it has submitted an application to the Food and Drug Administration (FDA) for emergency use of its bivalent (two-strain) COVID booster vaccine that targets the BA.4/BA.5 Omicron subvariants, following a similar move this week from Pfizer and BioNTech.

Pharmacists have important antimicrobial stewardship (AMS) roles yet limited literature exists on pharmacists’ knowledge and beliefs about antimicrobial resistance (AMR) and antimicrobials and how these beliefs influence antimicrobial supply in different countries.

Sunday marked the ninth anniversary of the Ghouta chemical massacre on August 21, 2013. The attack claimed the lives of at least 1,347 people in the East and West Ghouta suburbs of Damascus, and injured more than 10,626 others, more than two-thirds of whom were children and women. Every year, Syrians keep its memory alive, bringing the events and pain of that day back to the forefront. 

The inaugural OECD Survey on the Drivers of Trust in Public Institutions (Trust Survey) is a new measurement tool for democratic governments seeking to improve public confidence in government reliability, responsiveness, integrity, fairness and openness. Twenty-two OECD countries volunteered to participate in the first wave of the programme, taking a collective step forward to measure and better understand what drives people’s trust in public institutions in order to build further the resilience of their democracies. Most countries were surveyed in November-December 2021, with a few surveys taking place in 2020 and January-March 2022.

Tecovirimat, a little-known antiviral, shows promise against monkeypox. But human data and supplies of the drug are limited.

I’m a 29-year-old gay man living in New York City during the first major wave of monkeypox infections in the United States. As the CEO and co-founder of a health care startup, I am very connected to the world of public health — especially public health that impacts LGBTQ+ people.

Most office spaces in India fail to meet indoor air quality standards, according to a recent survey, which showed that of the 30 office spaces inspected, only one had all the indoor air contaminants within the prescribed limits.

Antimicrobial resistance (AMR) has become a global public health issue and antibiotic agents have lagged behind the rise in bacterial resistance.